ELANE and asthma: Evidence supporting this comes from clinical observations impaired MCC during exacerbations of asthma [1, 2], COPD [3] and CF [4] as well as experimental data that inhaled inflammatory mediators, such as neutrophil elastase slows whole lung MCC and tracheal mucus velocity (TMV).